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Abstract
Objectives
To evaluate the effect of storing commonly used rapid diagnostic tests above manufacturer-
recommended temperature (at 37°C), and the accuracy of delayed reading of oral fluid kits
with relevance to HIV self-testing programmes.
Design
A quality assurance study of OraQuick (OraSure), Determine HIV 1/2™ (Alere) and Uni-
Gold™ (Recombigen1).
Methods
Consecutive adults (18y) attending Ndirande Health Centre in urban Blantyre, Malawi in
January to April 2012 underwent HIV testing with two of each of the three rapid diagnostic
test kits stored for 28 days at either 18°C (optimally-stored) or at 37°C (pre-incubated).
Used OraQuick test kits were stored in a laboratory for delayed day 1 and subsequent
monthly re-reading was undertaken for one year.
Results
Of 378 individuals who underwent parallel testing, 5 (1.3%) were dropped from the final
analysis due to discordant or missing reference standard results (optimally-stored Deter-
mine and Uni-Gold). Compared to the diagnostic reference standard, OraQuick had a sensi-
tivity of 97.2% (95% CI: 93.6–99.6). There were 7 false negative results among all test kits
stored at 37°C and three false negatives among optimally stored kits. Excellent agreement
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between pre-incubated tests and optimally-stored tests with Kappa values of 1.00 for Deter-
mine and Uni-Gold; and 0.97 (95% CI: 0.95; 1.00) for OraQuick were observed. There was
high visual stability on re-reading of OraQuick, with only 1/375 pre-incubated and 1/371 opti-
mally-stored OraQuick kits changing from the initial result over 12 months.
Conclusion
Erroneous results observed during HIV testing in low income settings are likely to be due to
factors other than suboptimal storage conditions. Re-reading returned OraQuick kits may
offer a convenient and accurate quality assurance approach, including in HIV self-testing
programmes.
Introduction
Globally, an estimated 45% of people living with HIV are aware of their HIV status[1], far
below the 90% target set out recently by WHO and UNAIDS[1]. The greatest numbers of peo-
ple living with undiagnosed HIV are in sub-Saharan Africa [1], where fragile health and labora-
tory systems have hindered efforts to scale up HIV testing coverage [2]. In low-income, high
HIV burden countries with limited technological infrastructure, rapid diagnostic tests (RDTs)
are widely used in diagnostic algorithms [1].
RDT accuracy may be undermined by poor operator practice [3, 4], and by storage at ambi-
ent temperatures above manufacturer guidelines [5]. Poor accuracy of RDTs and subsequent
misclassification can result in a) if falsely diagnosed HIV-positive, unnecessary worry and initi-
ation on antiretroviral therapy; or b) if falsely diagnosed HIV-negative, missed opportunities
for linkage to HIV care and prevention services[6, 7].
The scale-up of HIV self-testing (HIVST) using oral fluid testing will pose additional chal-
lenges to maintaining accuracy in HIV testing programmes. Self-testing is defined by an indi-
vidual performing and interpreting their own HIV test result [8]. Oral fluid RDTs intended for
self-testing may be stored in uncontrolled settings (e.g. people’s houses) for prolonged periods
before use and are less amenable to formal quality assurance (QA) programmes [9]. We there-
fore set out to evaluate two aspects of RDT kit stability: the effect of prolonged field exposure
to high temperature on the accuracy of whole blood and oral fluid RDTs; and the stability of
oral RDT results with delayed visual re-reading.
Methods
Study design and participants
A quality assurance study of three HIV RDTs (OraQuick: OraSure Technologies, USA; Deter-
mine 1/2™: Alere, Waltham, USA; and Uni-Gold™: Recombigen1HIV, Trinity Biotech, Bray,
Ireland) was conducted at Ndirande Health Centre in Blantyre, Malawi. Participants were
recruited between 14th January and 5th March 2012 and visual re-reading of OraQuick kits con-
tinued until 30th April 2013. Participants were recruited from both HIV testing and counselling
(HTC) and antiretroviral treatment (ART) clinics. All consecutive adults (18 years) present-
ing for HIV testing or ART care during the study period were invited to participate regardless
of previous history of HIV testing.
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Definitions
Three HIV rapid diagnostic tests were evaluated in this study: OraQuick ADVANCE HIV I/II™
(OraSure Technologies, Bethlehem, USA; assembled in Thailand), Determine 1/2™ (Alere,
Waltham, USA) and Uni-Gold™ Recombigen1HIV, Trinity Biotech, Bray, Ireland).
Optimally-stored index tests. Intact packages of rapid diagnostic tests stored on-site in a
laboratory storage facility at a temperature of 18°C as recommended by the manufacturer (2–
27°C, 2–27°C and 2–30°C for OraQuick, Uni-Gold and Determine, respectively).
Pre-incubated index tests. Intact packages of rapid diagnostic tests pre-incubated for 28
days at 37°C in an incubator in a laboratory to mimic higher than manufacturer-specified
conditions.
Index tests and reference standard
Individuals who gave written or witnessed (thumb print) consent underwent HIV testing with
six RDTs: two each of OraQuick, Determine 1/2™ and Uni-Gold™. Pairs of RDTs had been
either optimally-stored or pre-incubated prior to use. One study nurse who had been trained in
the use of RDTs performed each test in parallel on the same participant using a venous blood
sample (Determine and Uni-Gold) and oral fluid (OraQuick).
The reference standard for HIV diagnosis comprised of a parallel HIV testing algorithm
consisting of two simultaneous HIV RDTs used in the Malawi National algorithm (Determine
and Uni-Gold™). Both RDTs included in the reference standard were required to return similar
results or a repeat of all optimally-stored tests was undertaken to resolve discordance.
Procedures
A study nurse sampled blood using venipuncture for use with blood RDTs and asked the par-
ticipant to perform an oral swab for use with OraQuick. The nurse read all six test kits at the
recommended time-points and gave results to the participant based on the reference standard.
Results were recorded as reactive or non-reactive, with a repeat in case of an invalid result.
Weakly reactive bands were recorded as positive. All blood RDTs and any remaining blood
samples collected were disposed of by the nurse at the study recruitment site.
Oral test kits (OraQuick), both optimally stored and pre-incubated at high temperatures,
were transported to a research laboratory for subsequent re-reading in order to assess visual
stability. The oral test kits were read upon arrival by a laboratory technician blinded to the orig-
inal results from the nurse. Test kits were then re-read at one week, two weeks, one month, 3
months, 6 months and 12 months to assess visual stability, with the reader blinded to previous
read results.
Ethical considerations
Ethical approval was obtained from the University of Malawi, College of Medicine Research
and Ethics Committee (COMREC) under ethical approval number: P.03/12/1186. All partici-
pants gave written or witnessed (thumb print) consent.
Statistical methods and sample size considerations
Stata version 13.0 (Stata Corp, Texas, USA) was used for data analysis. Estimates of sensitivity
and specificity with 95% confidence intervals (CI) for each index test and storage/read condi-
tion were computed by comparing pre-incubated kits and optimally stored OraQuick kits
against the reference diagnostic algorithm comprising of Determine and Uni-Gold in parallel.
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Further analysis of reliability was conducted by computing a Kappa statistic by comparing pre-
incubated and optimally-stored RDTs.
A total of 200 HIV positive and 200 HIV negative participants provided precision of +/- 2%
around our assumed estimate of sensitivity of 98% (95% binomial exact CI: 94%-99%) and
specificity of 99% for each RDT comparison with the reference standard.
Results
Characteristics of study participants
Of 404 individuals screened for eligibility, a total of 378 (93.6%) were recruited into the study
(Fig 1). Median age was 31 years (IQR 25–40), and 198 (52.4%) participants were male. The
majority (242, 64.0%) of participants had previously tested for HIV, with comparable propor-
tions of prior testing among men (121/238, 50.8%) and women (117/238, 49.2%; p = 0.096). A
total of 108 (28.6%) HIV-positive individuals were already on ART.
Sensitivity and specificity of index tests
Results from 5/378 (1.3%) participants were excluded from the computation of sensitivity and
specificity (3 excluded were due to discordant results between Determine and Uni-Gold and 2
due to missing result from 1 reference standard test). All RDTs had a sensitivity> 98.0%
Fig 1. Flow of participant recruitment and HIV testing.
doi:10.1371/journal.pone.0158107.g001
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except pre-incubated OraQuick with sensitivity 97.2% (95% CI: 93.6–99.6) Table 1. Specificity
was higher than 99.5% for all RDTs. There were seven false negative results in total across all
the pre-incubated RDTs compared with three false negatives when RDTs were optimally
stored.
Reliability of pre-incubated RDTs
There was excellent agreement between pre-incubated and optimally-stored RDTs with Kappa
of 1.00 for Determine and Uni-Gold (Table 2). Similar results were observed for pre-incubated
OraQuick, with Kappa of 0.97 (95% CI: 0.95; 1.00).
Visual stability of OraQuick RDT over12 months
In total, 375/378 pre-incubated OraQuick and 371/378 optimally-stored OraQuick RDTs were
re-read over a period of 12 months to assess the stability of visual reads. There was very high
reproducibility of results, with only 1/375 pre-incubated and 1/371 optimally-stored OraQuick
kits changing from the initial result. Both kits were initially read as positive and had at least
one subsequent positive read following the false negative read, which was recorded within a
month of testing.
Discussion
The main findings of this study were that the contribution of suboptimal storage to misclassifi-
cation of HIV results is likely to be relatively minor, and that re-reading of used oral fluid tests
(OFT) may be a feasible and valid option for implementing quality assurance (QA) of Ora-
Quick test kits as these are scaled up for use by less qualified personnel, including during HIV
self-testing [9].
Pre-incubating HIV RDTs at 37°C for 28 days did not substantially affect their diagnostic
accuracy, and, in all but two cases (both known to be taking ART), initial visual read results on
OraQuick test kits were stable over the one-year follow up period in this study. The results
Table 1. Sensitivity and specificity compared to a reference standard (parallel testing).
RDT Kit TP/FN Sensitivity (95% CI) TN/FP Speciﬁcity (95% CI)
OraQuick Pre-incubated 175/5 97.2 (93.6–99.6) 190/0 100 (98.1–100)
Determine Pre-incubated 180/1 99.4 (97.1–100) 189/1 99.5 (97.1–100)
Uni-Gold Pre-incubated 180/1 99.4 (97.0–100) 189/0 100 (98.1–100)
OraQuick Optimally-stored 174/3 98.3 (95.2–99.7) 186/1 99.5 (97.1–100)
RDT: rapid diagnostic test
CI: conﬁdence interval; TP: true positive; FN: false negative; TN: true negative; FP: false positive
doi:10.1371/journal.pone.0158107.t001
Table 2. Reliability comparison of optimally stored and pre-incubated tests.
RDT Kit Both positive Both negative Positive: negative Negative: positive Kappa (95% CI)
Determine 185 191 0 0 1.00 (1.00; 1.00)
Uni-Gold 184 191 0 0 1.00 (1.00; 1.00)
OraQuick 176 187 4 1 0.97 (0.95; 1.00)
RDT: rapid diagnostic test
CI: conﬁdence interval
doi:10.1371/journal.pone.0158107.t002
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from our study demonstrate the stability of OraQuick, Determine and Uni-Gold when pre-
incubated at 37°C for 28 days, which is an important consideration in resource poor settings
where poor storage conditions are common [5].
The scale up of HTC in Africa was not initially accompanied by systematic QA or retrain-
ing, but the need to build systematic proficiency testing into routine HIV testing programmes
has become strikingly apparent with reports of poor operator practice and high rates of mis-
classification in many African national programmes [10, 11]. Lessons from this experience
need to be applied to HIVST and other types of highly decentralised community-based HIV
testing services.
Our results, showing robustness of the kits to poor storage and late read, are consistent with
current understanding that identifies poor operator practice as the major determinant of mis-
classification [10, 11], in part reflecting “task-shifting” of HTC to cadres such as lay counsel-
lors. The introduction of very simple oral fluid test kits will enable further task-shifting
including as part of HIV self-testing (HIVST) [9]. Systems for providing external QA for oral
fluid tests and HVST are not yet well established. These data provide reassurance that countries
currently revising QA systems to accommodate oral fluid tests and HIVST could consider
including systems based on visual re-reading. While outside of manufacturer’s recommenda-
tions, our results suggest that for OraQuick at least, this provides a simple and practical
approach to monitoring operator-dependant misclassifications if used kits can be retrieved
along with the users’ interpretation of results. In this context, we have previously reported a
high willingness to return HIVST kits to the distributor, together with a self-completed ques-
tionnaire that includes results interpretation [9].
More work is needed to develop fully comprehensive external quality assurance (EQA) sys-
tems for oral fluid RDTs. False-positive results have been described for OFTs, particularly in
the context of pregnancy and concomitant infections [12, 13]. With respect to sensitivity, sub-
sets where oral-based RDTs should be used with caution because of reports of lower than
expected sensitivity [14] are patients at high risk of acute HIV infection [15] and those estab-
lished on ART. In this study, we report one potential false-positive from 369 optimally and 375
sub-optimally stored OFT kits, and a suggestion that poor storage conditions may reduce sensi-
tivity but with no obvious effects on specificity. We also report two participants already on
ART who had an observed change in the result of their oral test kits when re-read over time.
Otherwise, there was minimal change in the interpretation of used OraQuick RDT results
when read up to one year after testing in this relatively small sample.
The implementation of a multistep approach to HIV testing has been recommended [1],
and it will be vital to have rigorous QA mechanisms in place in an effort to reduce error
amongst testers in both home-based and laboratory settings. Re-evaluation of used test kits
could contribute to internal and external quality assurance programs [1, 16].
There were three notable limitations in this study. First of all, our reference standard was
not carried out separately from the index test rendering blinding of index tests impossible. Sec-
ondly, we did not exclude patients already on ART, despite the known issues of low sensitivity
of RDTs in this important subgroup. Lastly, we did not measure the impact of humidity a long
with temperature in this study.
In summary, this study has shown that prolonged exposure of RDTs to temperatures above
manufacturer’s recommendation did not substantially affect the sensitivity and specificity of
commonly used RDTs including OraQuick OFT. Furthermore, visual interpretation of Ora-
Quick results was highly stable for 12 months after testing, supporting the use of re-reading of
used test kits as part of programmatic quality assurance.
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